FI885303A0 - Proteolytiska fragment och syntetiska peptider, vilka hindrar bindning av von willebrand-faktorn till membranglykoproteinet ib i blodplaettar. - Google Patents

Proteolytiska fragment och syntetiska peptider, vilka hindrar bindning av von willebrand-faktorn till membranglykoproteinet ib i blodplaettar.

Info

Publication number
FI885303A0
FI885303A0 FI885303A FI885303A FI885303A0 FI 885303 A0 FI885303 A0 FI 885303A0 FI 885303 A FI885303 A FI 885303A FI 885303 A FI885303 A FI 885303A FI 885303 A0 FI885303 A0 FI 885303A0
Authority
FI
Finland
Prior art keywords
membranglykoproteinet
hindrar
faktorn
blodplaettar
peptider
Prior art date
Application number
FI885303A
Other languages
English (en)
Other versions
FI885303A (fi
Inventor
Theodore S Zimmerman
Zaverio M Ruggeri
Richard A Houghten
Vicente Vincete
Hiroshi Mohri
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI885303A0 publication Critical patent/FI885303A0/fi
Publication of FI885303A publication Critical patent/FI885303A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI885303A 1987-11-17 1988-11-16 Proteolytiska fragment och syntetiska peptider, vilka hindrar bindning av von willebrand-faktorn till membranglykoproteinet ib i blodplaettar. FI885303A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12145487A 1987-11-17 1987-11-17

Publications (2)

Publication Number Publication Date
FI885303A0 true FI885303A0 (fi) 1988-11-16
FI885303A FI885303A (fi) 1989-05-18

Family

ID=22396842

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885303A FI885303A (fi) 1987-11-17 1988-11-16 Proteolytiska fragment och syntetiska peptider, vilka hindrar bindning av von willebrand-faktorn till membranglykoproteinet ib i blodplaettar.

Country Status (9)

Country Link
EP (1) EP0317278A3 (fi)
JP (1) JPH01221394A (fi)
KR (1) KR890008169A (fi)
AU (1) AU626813B2 (fi)
DK (1) DK639988A (fi)
FI (1) FI885303A (fi)
IL (1) IL88308A0 (fi)
NO (1) NO885108L (fi)
NZ (1) NZ226964A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
CA2067250C (en) * 1989-10-20 2008-06-17 Bruce Furie Inhibition of padgem-mediated cell binding
US6008193A (en) * 1990-03-02 1999-12-28 Bio-Technology General Corp. Methods of using human von Willebrand factor GPIb binding domain polypeptides
US5849536A (en) * 1990-03-02 1998-12-15 Bio-Technology General Corp. Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US5427939A (en) * 1992-01-06 1995-06-27 The Scripps Research Institute Expression vectors encoding alloantigens of glycoprotein Ibα
WO1993016712A1 (en) * 1992-02-26 1993-09-02 The Scripps Research Institute MUTANT GPIbα FRAGMENTS AND RECOMBINANT EXPRESSION THEREOF
AR035779A1 (es) 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
NZ544165A (en) * 2003-06-11 2008-12-24 Wyeth Corp Platelet glycoprotein IB alpha variant fusion polypeptides and methods of use thereof
US7887837B2 (en) 2006-01-06 2011-02-15 Shinji Takeoka Drug delivery material
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin

Also Published As

Publication number Publication date
EP0317278A2 (en) 1989-05-24
JPH01221394A (ja) 1989-09-04
FI885303A (fi) 1989-05-18
NO885108D0 (no) 1988-11-16
DK639988D0 (da) 1988-11-16
EP0317278A3 (en) 1989-11-23
DK639988A (da) 1989-05-18
AU626813B2 (en) 1992-08-13
KR890008169A (ko) 1989-07-10
AU2560588A (en) 1989-05-18
NO885108L (no) 1989-05-18
IL88308A0 (en) 1989-06-30
NZ226964A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
FI886006A (fi) Foerfarande och anordning foer lagring, utmatning och paofoering av kirurgiska faestklaemmor.
FI892663A0 (fi) Foerfarande foer stabilisering, solidifiering och lagring av avfall.
FI863797A (fi) Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma.
FI881086A0 (fi) Olja-i-vatten-emulsioner, foerfarande foer deras framstaellning och deras anvaendning.
FI883129A0 (fi) Foerfarande foer framstaellning av organiserade strukturer av kollagen, speciellt av maenskligt ursprung och motsvarande organiserade strukturer av kollagen.
FI885581A (fi) Anordning foer mottagning, transportering, foerminskning och frammatning av foderblock.
FI884505A (fi) Immunoanalys, i vilken anvaends igg-uppsnappande antikroppar och detekteringssystem foer flera monoklonala antikroppar.
FI885303A0 (fi) Proteolytiska fragment och syntetiska peptider, vilka hindrar bindning av von willebrand-faktorn till membranglykoproteinet ib i blodplaettar.
FI872965A0 (fi) Foerfarande och anordning foer kapning av papper, isynnerhet foerperforerat papper.
FI872147A (fi) Fiskfoder, foerfarande foer framstaellning av detsamma och utfodringsfoerfarande.
FI882993A (fi) Silikapartiklar, saett foer framstaellning av silikapartiklar och anvaendning av dessa.
FI883200A (fi) Foerfarande, anordning och tillbehoer foer maetning av vaevnadsplasminogenaktivator-aktivitet.
FI880661A0 (fi) Vatten-i olja-emulsioner, vilka innehaoller amidas och behandlingsfoerfarande foer dylika emulsioner.
FI875327A (fi) Foerfarande och anordning foer framstaellning av betongstomelement, isynnerhet bjaelkar.
FI883937A (fi) Anlaeggning foer kapning, lindning och bindning av lindningsgods.
FI882251A (fi) Keramiskt foeremaol, raosatskomposition och foerfarande.
FI873317A (fi) Foerfarande och anordning foer bestrykning av laongstraeckta staolstycken, isynnerhet betongstaol och staolprofiler.
FI872588A0 (fi) Foerfarande, saendare och mottagare foer oeverfoerande av digitalisk tillaeggsinformation.
FI870232A0 (fi) Foerfarande och anordning foer foerflyttning av en roerlig anordning, saosom en hisskorg.
FI881909A0 (fi) Nitrosoureaderivator, deras framstaellning och anvaendning av desamma.
FI874133A0 (fi) Foerfarande och anordning foer framstaellning av betongstomelement, isynnerhet bjaelkar.
FI875035A0 (fi) Foerfarande och anordning foer ytbehandling av byggnadsstycken, liksom tegel och motsvarande.
FI883920A (fi) Foerfarande foer formning av en transportenhet, en underlagskonstruktion och en behandlingsanordning.
FI872498A0 (fi) Foerfarande, glidgjutningsanordning och armering foer gjutning av konstruktionen.
FI872724A (fi) Cellplast, foerfarande foer framstaellning av cellplast och anvaendningen av cellplast.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION